CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
35 hedge funds and large institutions have $7.2M invested in Crescent Biopharma, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 37 closing their positions.
Holders
35
Holders Change
-34
Holders Change %
-49.28%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
16
Closed
37
Calls
$675K
Puts
$44K
Net Calls
+$631K
Net Calls Change
-$823K
